A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma

Conditions:   Advanced Solid Tumor;   Cutaneous T-cell Lymphoma (CTCL) Intervention:   Drug: SIM1811-03 Sponsor:   Jiangsu Simcere Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials